5901 - 5910 of 9033 Results
Title
Year
-
OPENTitle: The GBA1 D409V mutation exacerbates synuclein pathology to differing extents in two alpha-synuclein modelsJournal Name: Disease Models & MechanismsPublisher: The Company of BiologistsVol: 15Issue #: 6Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1242/dmm.049192Best OA location URL: https://journals.biologists.com/dmm/article-pdf/15/6/dmm049192/2145803/dmm049192.pdfCitation Count: 18
-
OPENTitle: Candidate inflammatory biomarkers display unique relationships with alpha-synuclein and correlate with measures of disease severity in subjects with Parkinson’s diseaseJournal Name: Journal of NeuroinflammationPublisher: Springer Science and Business Media LLCVol: 14Issue #: 1Start Page: 164End Page: 164Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s12974-017-0935-1Best OA location URL: https://jneuroinflammation.biomedcentral.com/track/pdf/10.1186/s12974-017-0935-1Citation Count: 105
- Crossroads in GDNF therapy for Parkinson's disease2006RESTRICTEDTitle: Crossroads in GDNF therapy for Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 21Issue #: 2Start Page: 136End Page: 141Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.20861Citation Count: 174
-
OPENTitle: Quantitative proteomics and phosphoproteomics of urinary extracellular vesicles define putative diagnostic biosignatures for Parkinson’s diseaseJournal Name: Communications MedicinePublisher: Springer Science and Business Media LLCVol: 3Issue #: 1Start Page: 64End Page: 64Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s43856-023-00294-wBest OA location URL: https://www.nature.com/articles/s43856-023-00294-w.pdfCitation Count: 42
-
OPENTitle: Correction: Data Sharing Goals for Nonprofit Funders of Clinical TrialsJournal Name: Journal of Participatory MedicinePublisher: JMIR Publications Inc.Vol: 13Issue #: 2Start Page: e31371End Page: e31371Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.2196/31371Best OA location URL: https://jopm.jmir.org/2021/2/e31371/PDFCitation Count: 1
- Longitudinal analyses of cerebrospinal fluid α‐Synuclein in prodromal and early Parkinson's disease2019OPENTitle: Longitudinal analyses of cerebrospinal fluid α‐Synuclein in prodromal and early Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 34Issue #: 9Start Page: 1354End Page: 1364Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.27806Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.27806Citation Count: 139
-
OPENTitle: Longitudinal Analysis of Multiple Neurotransmitter Metabolites in Cerebrospinal Fluid in Early Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 8Start Page: 1972End Page: 1978Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mds.28608Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28608Citation Count: 40
-
OPENTitle: Lack of evidence for genetic association of saposins A, B, C and D with Parkinson’s diseaseJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 143Issue #: 9Start Page: e72End Page: e72Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/brain/awaa214Best OA location URL: https://academic.oup.com/brain/article-pdf/143/9/e72/34280049/awaa214.pdfCitation Count: 14
-
OPENTitle: Discordance of Dopaminergic Dysfunction and Subcortical Atrophy by α‐Synuclein Status in Sporadic and Genetic Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 41Issue #: 5Start Page: 1101End Page: 1113Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.70186Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.70186Citation Count: 2
- At last, a randomised controlled trial of apomorphine infusion2018RESTRICTEDTitle: At last, a randomised controlled trial of apomorphine infusionJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 17Issue #: 9Start Page: 732End Page: 733Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(18)30284-9Citation Count: 3